AM

Healthcare · Pharmaceuticals

Ambalal Sarabhai Enterprises Ltd (AMBALALSA)

₹38.96

Mkt cap
₹296 Cr
P/E ratio
19.10
P/B
1.83
Div yield
0.00%
ROE
12.40%
ROCE
11.70%
EPS (TTM)
₹2.04
Book value
₹21
52W range
30–50
Sector
Healthcare

Price history

Previous close

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics [1]

NSE AMBALALSABSE 500009
Health check
Mixed
ValuationCheap
ProfitabilityAverage
GrowthLow
TechnicalsNeutral
52-week range
−22.05% from high
₹39
₹30+29.22% from low₹50
Current
₹38.96
Prev close
₹39.14
Day
−0.46%
Price performance
1D
−0.46%
1W
+1.91%
1M
+6.92%
3M
−18.39%
6M
+18.96%
1Y
—
YTD
+20.06%

Financials

Revenue, profit & margin
P/E ratio
19.1×
AMBALALSA is 41% below the sector median of 32.5×
AMBALALSA19.1×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales40.0143.1154.3540.7044.7045.9764.8140.3444.4552.0065.4943.5658.13
YoY Sales growth-14.58%+21.92%+22.30%+12.74%+11.72%+6.63%+19.25%-0.88%-0.56%+13.12%+1.05%+7.98%+30.78%
Expenses39.0040.5849.7040.2342.1646.6759.5138.8844.0947.9259.7939.0155.78
Operating Profit1.012.534.650.472.54-0.705.301.460.364.085.704.552.35
OPM %2.52%5.87%8.56%1.15%5.68%-1.52%8.18%3.62%0.81%7.85%8.70%10.45%4.04%
Other Income2.851.634.792.302.805.76-5.378.361.621.943.022.461.39
Interest0.920.990.900.951.221.140.961.010.960.701.420.981.04
Depreciation1.141.130.250.981.010.991.020.881.060.961.051.351.39
Profit before tax1.802.048.290.843.112.93-2.057.93-0.044.366.254.681.31
Tax %40.00%34.31%-8.69%59.52%15.76%23.89%-86.83%-3.66%1,300.00%16.51%-4.00%14.96%48.85%
Net Profit1.081.339.020.352.622.23-0.278.22-0.563.646.503.980.67
EPS in Rs0.140.171.180.050.340.29-0.041.07-0.070.470.850.520.09
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
31.36%Promoter
Promoters31.36%
FIIs0.00%
DIIs0.00%
Public68.62%0.02
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Ambalal Sarabhai₹38.3119.142960.00%1+219.64%58+30.78%11.69%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings